BG
Bellevue Group’s Eli Lilly LLY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $31.9M | Sell |
40,920
-2,727
| -6% | -$2.13M | 0.7% | 37 |
|
|
2025
Q1 | $36M | Sell |
43,647
-1,818
| -4% | -$1.5M | 0.81% | 30 |
|
|
2024
Q4 | $35.1M | Buy |
45,465
+1,219
| +3% | +$941K | 0.68% | 34 |
|
|
2024
Q3 | $39.2M | Sell |
44,246
-5,428
| -11% | -$4.81M | 0.64% | 43 |
|
|
2024
Q2 | $45M | Sell |
49,674
-8,291
| -14% | -$7.51M | 0.73% | 34 |
|
|
2024
Q1 | $45.1M | Buy |
57,965
+1,753
| +3% | +$1.36M | 0.69% | 46 |
|
|
2023
Q4 | $32.8M | Sell |
56,212
-25,329
| -31% | -$14.8M | 0.5% | 59 |
|
|
2023
Q3 | $43.8M | Sell |
81,541
-13,614
| -14% | -$7.31M | 0.71% | 43 |
|
|
2023
Q2 | $44.6M | Buy |
95,155
+84,391
| +784% | +$39.6M | 0.64% | 52 |
|
|
2023
Q1 | $3.7M | Sell |
10,764
-291
| -3% | -$99.9K | 0.05% | 109 |
|
|
2022
Q4 | $4.04M | Buy |
11,055
+1,565
| +16% | +$573K | 0.05% | 113 |
|
|
2022
Q3 | $3.07M | Buy |
9,490
+8,521
| +879% | +$2.76M | 0.04% | 115 |
|
|
2022
Q2 | $314K | Buy |
+969
| New | +$314K | ﹤0.01% | 152 |
|
|
2022
Q1 | – | Sell |
-7,552
| Closed | -$2.09M | – | 190 |
|
|
2021
Q4 | $2.09M | Buy |
+7,552
| New | +$2.09M | 0.02% | 146 |
|
|
2018
Q1 | – | Sell |
-241,262
| Closed | -$20.4M | – | 130 |
|
|
2017
Q4 | $20.4M | Hold |
241,262
| – | – | 2.13% | 13 |
|
|
2017
Q3 | $20.6M | Buy |
241,262
+60,189
| +33% | +$5.15M | 2.16% | 11 |
|
|
2017
Q2 | $14.9M | Buy |
181,073
+49,673
| +38% | +$4.09M | 1.76% | 16 |
|
|
2017
Q1 | $11.1M | Buy |
131,400
+96,400
| +275% | +$8.11M | 1.47% | 26 |
|
|
2016
Q4 | $2.57M | Hold |
35,000
| – | – | 0.53% | 50 |
|
|
2016
Q3 | $2.81M | Hold |
35,000
| – | – | 0.51% | 57 |
|
|
2016
Q2 | $2.76M | Hold |
35,000
| – | – | 0.52% | 57 |
|
|
2016
Q1 | $2.52M | Buy |
+35,000
| New | +$2.52M | 0.46% | 70 |
|